Updated Jul 16, 2026
NOUGUES MAXIMO F has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $111K.
Maximo F. Nougues is the Chief Financial Officer of Puma Biotechnology, Inc., a biopharmaceutical company focused on innovative cancer treatments. He has been involved in the company's financial operations, contributing to its mission of enhancing cancer care.
| Role | Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | PBYI | PUMA BIOTECHNOLOGY, INC. | S — Open-market sale | 9.4K | $8.26 | $78K |
| 2026-02-21 | PBYI | PUMA BIOTECHNOLOGY, INC. | A — Grant or award | 46.7K | $0.00 | |
| 2025-07-08 | PBYI | PUMA BIOTECHNOLOGY, INC. | S — Open-market sale | 3.9K | $3.54 | $14K |
| 2025-07-08 | PBYI | PUMA BIOTECHNOLOGY, INC. | S — Open-market sale | 5.6K | $3.53 | $20K |
Maximo F. Nougues is the Chief Financial Officer of Puma Biotechnology, Inc., a biopharmaceutical company focused on innovative cancer treatments. He has been involved in the company's financial operations, contributing to its mission of enhancing cancer care.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($111K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live NOUGUES MAXIMO F profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.